In today’s episode, we welcome back Dr. Amar Kelkar for part 2 of our two-part discussion on allogeneic transplant. In this episode, we build on our prior discussion regarding transplant, this time focusing on transplant for the treatment of AML.
Episode contents:
- What are the different conditioning regimens available?
- How do we decide which regimen ... Show More
Sep 17
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ... Show More
36m 11s
Sep 10
Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an u ... Show More
29m 51s
Jun 2025
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. </ ... Show More
30m 11s
Oct 2024
ASRM Today: Equity, Access, and Innovation, Episode Nine: Reflections
<p>In this ASRM Today podcast episode, host Jeffrey Hayes reflects on the theme of Season 2, "equity, access, and innovation," in reproductive medicine. The season explores these ideas through personal, political, and cultural lenses, including an analysis of pop culture's influe ... Show More
4m 52s